No one cares about NICE. We care about FDA, and they approved it for burns. This is the US we’re discussing, not the UK and their status-quo-maintaining bureaucrats. NICE has no relevance here, so why do you keep repeating that point? Is that the best you got? If you were as smart as you think you are, you would have closed out your short position at RCEL $4-$5.
Ann: AVITA Medical to Announce First Quarter 2023 Results, page-23
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
